1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 United States Cancer Diagnostics Market - Introduction
4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence
5 United States Cancer Diagnostics Market Landscape
5.1 Historical and Current Market Trends (2018-2023)
5.2 Market Forecast (2024-2032)
6 United States Cancer Diagnostics Market - Breakup by Product
6.1 Consumables
6.1.1 Overview
6.1.2 Historical and Current Market Trends (2018-2023)
6.1.3 Market Segmentation
6.1.3.1 Antibodies
6.1.3.2 Kits and Reagents
6.1.3.3 Probes
6.1.3.4 Others
6.1.4 Market Forecast (2024-2032)
6.2 Instruments
6.2.1 Overview
6.2.2 Historical and Current Market Trends (2018-2023)
6.2.3 Market Segmentation
6.2.3.1 Pathology-Based Instruments
6.2.3.2 Imaging Instruments
6.2.3.3 Biopsy Instruments
6.2.4 Market Forecast (2024-2032)
7 United States Cancer Diagnostics Market - Breakup by Technology
7.1 IVD Testing
7.1.1 Overview
7.1.2 Historical and Current Market Trends (2018-2023)
7.1.3 Market Segmentation
7.1.3.1 Polymerase Chain Reaction (PCR)
7.1.3.2 In Situ Hybridization (ISH)
7.1.3.3 Immunohistochemistry (IHC)
7.1.3.4 Next-generation Sequencing (NGS)
7.1.3.5 Microarrays
7.1.3.6 Flow Cytometry
7.1.3.7 Immunoassays
7.1.3.8 Others
7.1.4 Market Forecast (2024-2032)
7.2 Imaging
7.2.1 Overview
7.2.2 Historical and Current Market Trends (2018-2023)
7.2.3 Market Segmentation
7.2.3.1 Magnetic Resonance Imaging (MRI)
7.2.3.2 Computed Tomography (CT)
7.2.3.3 Positron Emission Tomography (PET)
7.2.3.4 Mammography
7.2.3.5 Ultrasound
7.2.4 Market Forecast (2024-2032)
7.3 Biopsy Technique
7.3.1 Overview
7.3.2 Historical and Current Market Trends (2018-2023)
7.3.3 Market Forecast (2024-2032)
8 United States Cancer Diagnostics Market - Breakup by Application
8.1 Breast Cancer
8.1.1 Overview
8.1.2 Historical and Current Market Trends (2018-2023)
8.1.3 Market Forecast (2024-2032)
8.2 Lung Cancer
8.2.1 Overview
8.2.2 Historical and Current Market Trends (2018-2023)
8.2.3 Market Forecast (2024-2032)
8.3 Colorectal Cancer
8.3.1 Overview
8.3.2 Historical and Current Market Trends (2018-2023)
8.3.3 Market Forecast (2024-2032)
8.4 Melanoma
8.4.1 Overview
8.4.2 Historical and Current Market Trends (2018-2023)
8.4.3 Market Forecast (2024-2032)
8.5 Others
8.5.1 Historical and Current Market Trends (2018-2023)
8.5.2 Market Forecast (2024-2032)
9 United States Cancer Diagnostics Market - Breakup by End User
9.1 Hospitals and Clinics
9.1.1 Overview
9.1.2 Historical and Current Market Trends (2018-2023)
9.1.3 Market Forecast (2024-2032)
9.2 Diagnostic Laboratories
9.2.1 Overview
9.2.2 Historical and Current Market Trends (2018-2023)
9.2.3 Market Forecast (2024-2032)
9.3 Others
9.3.1 Historical and Current Market Trends (2018-2023)
9.3.2 Market Forecast (2024-2032)
10 United States Cancer Diagnostics Market – Breakup by Region
10.1 Northeast
10.1.1 Overview
10.1.2 Historical and Current Market Trends (2018-2023)
10.1.3 Market Breakup by Product
10.1.4 Market Breakup by Technology
10.1.5 Market Breakup by Application
10.1.6 Market Breakup by End User
10.1.7 Key Players
10.1.8 Market Forecast (2024-2032)
10.2 Midwest
10.2.1 Overview
10.2.2 Historical and Current Market Trends (2018-2023)
10.2.3 Market Breakup by Product
10.2.4 Market Breakup by Technology
10.2.5 Market Breakup by Application
10.2.6 Market Breakup by End User
10.2.7 Key Players
10.2.8 Market Forecast (2024-2032)
10.3 South
10.3.1 Overview
10.3.2 Historical and Current Market Trends (2018-2023)
10.3.3 Market Breakup by Product
10.3.4 Market Breakup by Technology
10.3.5 Market Breakup by Application
10.3.6 Market Breakup by End User
10.3.7 Key Players
10.3.8 Market Forecast (2024-2032)
10.4 West
10.4.1 Overview
10.4.2 Historical and Current Market Trends (2018-2023)
10.4.3 Market Breakup by Product
10.4.4 Market Breakup by Technology
10.4.5 Market Breakup by Application
10.4.6 Market Breakup by End User
10.4.7 Key Players
10.4.8 Market Forecast (2024-2032)
11 United States Cancer Diagnostics Market – Competitive Landscape
11.1 Overview
11.2 Market Structure
11.3 Market Player Positioning
11.4 Top Winning Strategies
11.5 Competitive Dashboard
11.6 Company Evaluation Quadrant
12 Profiles of Key Players
12.1 Company A
12.1.1 Business Overview
12.1.2 Product Portfolio
12.1.3 Business Strategies
12.1.4 SWOT Analysis
12.1.5 Major News and Events
12.2 Company B
12.2.1 Business Overview
12.2.2 Product Portfolio
12.2.3 Business Strategies
12.2.4 SWOT Analysis
12.2.5 Major News and Events
12.3 Company C
12.3.1 Business Overview
12.3.2 Product Portfolio
12.3.3 Business Strategies
12.3.4 SWOT Analysis
12.3.5 Major News and Events
12.4 Company D
12.4.1 Business Overview
12.4.2 Product Portfolio
12.4.3 Business Strategies
12.4.4 SWOT Analysis
12.4.5 Major News and Events
12.5 Company E
12.5.1 Business Overview
12.5.2 Product Portfolio
12.5.3 Business Strategies
12.5.4 SWOT Analysis
12.5.5 Major News and Events
Company names have not been provided here as this is a sample TOC. The complete list is provided in the report.
13 United States Cancer Diagnostics Market - Industry Analysis
13.1 Drivers, Restraints, and Opportunities
13.1.1 Overview
13.1.2 Drivers
13.1.3 Restraints
13.1.4 Opportunities
13.2 Porters Five Forces Analysis
13.2.1 Overview
13.2.2 Bargaining Power of Buyers
13.2.3 Bargaining Power of Suppliers
13.2.4 Degree of Competition
13.2.5 Threat of New Entrants
13.2.6 Threat of Substitutes
13.3 Value Chain Analysis
14 Appendix